New Horizons in the Treatment of Osteosarcoma

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging

Amin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K., Meyer, L., Gress, D. M., Byrd, D. R., & Winchester, D. P. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21388 · Cited by 6,531

Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms

Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948

A System for the Surgical Staging of Musculoskeletal Sarcoma

Enneking, W. F., Spanier, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,661

Massive genomic rearrangement acquired in a single catastrophic event during cancer development

Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Bielack, S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.776 · Cited by 2,391

Mutational Processes Molding the Genomes of 21 Breast Cancers

Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909

Angio-Associated Migratory Cell Protein (AAMP) Regulates the Hippo/YAP Pathway and Mitochondrial Functionality to Drive Osteosarcoma MetastasisPreprint

Zhan, F., Chen, Z., Xie, C., Xiang, S., Deng, Q., Li, H., Tian, L., Jian, C., Xiang, J., Ou, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1208015/v1

CircPARD3 promotes osteosarcoma proliferation and metastasis through regulating the miRNA-1294/ SKIL PathwayPreprint

Lv, G., Pan, Y., Wang, X., Li, Y., & Li, X. (2022) · Research Square · doi:10.21203/rs.3.rs-2018243/v1

A case of combination treatment of femoral osteosarcoma

Filimonov, A. A., Kutakov, N. M., Chekini, D. A., Musaev, E. M., Akhov, A. O., Жуков, А. Г., Тимофеева, О. Л., Abbasbeyli, F. M., Ryabukhina, Y. E., Zeynalova, P. A., et al. (2022) · MD-Onco · doi:10.17650/2782-3202-2022-2-4-56-62

Systemische Therapie von Osteosarkomen*

Bielack, S., Reichardt, P., Lindner, L. H., & Hecker‐Nolting, S. (2023) · InFo Hämatologie + Onkologie · doi:10.1007/s15004-023-9846-8

Herbal used as Epigenetic for Cancer Treatment

Navadiya, K. B., Goti, B. D., Raloliya, U. D., & Gamit, K. S. (2023) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.2.1.35

Data from Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

Cillo, A. R., Mukherjee, E., Bailey, N. G., Onkar, S., Daley, J. D., Salgado, C. M., Li, X., Liu, D., Ranganathan, S., Burgess, M. A., et al. (2023) · doi:10.1158/1078-0432.c.6532980

To construct a prognostic model and identify target gene of macrophage polarization by machine learning for predicting immune responses in osteosarcoma and pan- cancerPreprint

Wang, D., Peng, Y., Tong, Z., Li, Z., Huang, L., Zeng, J., Li, J., Miao, J., & Chen, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3116741/v1

Ultrasound-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by enhancement of tumor microenvironment responsive deliveryPreprint

Li, Z., Liu, K., Ye, Z., Chen, Q., Song, Y., Lu, H., Zhang, Y., Zhang, Y., Ma, X., Zan, P., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3622042/v1

Zinc Oxide Nanoparticles (ZnO NPs) Treated Two Types of Osteosarcoma Cell Lines for Identifying Differentially Expressed Genes

Guo, X., Wang, L., Yang, H., & He, G. (2023) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2023.3722

Data from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

Schott, C. R., Koehne, A. L., Sayles, L. C., Young, E. P., Luck, C., Yu, K., Lee, A. G., Breese, M. R., Leung, S. G., Xu, H., et al. (2024) · doi:10.1158/1078-0432.c.7077821.v1

Data from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

Schott, C. R., Koehne, A. L., Sayles, L. C., Young, E. P., Luck, C., Yu, K., Lee, A. G., Breese, M. R., Leung, S. G., Xu, H., et al. (2024) · doi:10.1158/1078-0432.c.7077821

Utilidad de los estudios genómicos basados en paneles de NGS (Next Generation Sequencing) para el manejo clínico de los sarcomas en pacientes pediátricos

Gutiérrez, M. (2023) · doi:10.15581/10171/69151

Additional file 1 of Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma

Chen, W., Liao, Y., Sun, P., Tu, J., Zou, Y., Ji, F., Chen, Z., Li, H., Chen, J., Peng, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25010324

Additional file 1 of Long intergenic non-coding RNA DIO3OS promotes osteosarcoma metastasis via activation of the TGF-β signaling pathway: a potential diagnostic and immunotherapeutic target for osteosarcoma

Yuan, J., Jia, J., Wu, T., Zhi, D., Chen, Q., Zhang, J., Wu, Z., Yuan, Z. K., Zhao, X., Liu, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24202645

Additional file 2 of Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling

Yu, L., Zhu, H., Wang, Z., Huang, J., Zhu, Y., Fan, G., Wang, Y., Chen, X., & Zhou, G. (2022) · Figshare · doi:10.6084/m9.figshare.20521598

Additional file 3 of Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling

Yu, L., Zhu, H., Wang, Z., Huang, J., Zhu, Y., Fan, G., Wang, Y., Chen, X., & Zhou, G. (2022) · Figshare · doi:10.6084/m9.figshare.20521601

CT-derived Radiomics Predicts the Efficacy of Tyrosine Kinase Inhibitors in Osteosarcoma Patients with Pulmonary Metastasis

Zhou, S., Liu, Q., Fu, Y., Du, L., Bao, Q., Zhang, Z., Xu, Z., Yan, F., Li, M., Liu, R., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.101993

Molecular mechanism of RBM14-mediated promotion of proliferation, migration, and invasion in osteosarcoma

Lin, S., Xiong, J., Zhou, F., Fu, J., Luo, H., Wan, Z., Luo, J., & Cao, K. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2070

Current status and future directions of systemic therapy in high-grade bone sarcomas

Machak, G. N. (2024) · N N Priorov Journal of Traumatology and Orthopedics · doi:10.17816/vto624147

A newly constructed STC2/FPR1 dual genes signature works as a prognosis risk indicator with implication in the macrophages dominated and TIM-3 checkpoint related osteosarcoma immune landscapePreprint

Ma, W., Miao, L., Liu, S., Zeng, Z., Li, J., Wang, F., Shen, N., Yang, Z., Gao, L., & Wang, C. (2024) · Research Square · doi:10.21203/rs.3.rs-5612703/v1

Strategies for Constructing Osteosarcoma 3D Culture Models and Progress in Their Applications

Qin, C., Huang, N., Qin, C., Huang, C., Qiu, Z., Wang, J., Fu, W. D., Liu, W., Peng, W., & Lan, C. (2024) · International Journal of Biology and Life Sciences · doi:10.54097/h5e7p918

Blood Transfusion and Survival of Children, Adolescent, and Young Adult Patients with Osteosarcoma: A Multicenter Retrospective Cohort Study

Cho, S., Fierstein, J. L., Khalaf, R. T., Morrison, J. M., & Metts, J. L. (2024) · Cancers · doi:10.3390/cancers17010097

PLAC8 Facilitates Osteosarcoma Growth and Metastasis by Upregulating CXCL5 Expression via miR-363-3p

Huang, X., Zhang, Y., Zhang, Y., Liu, Y., Han, X., Zhang, C., Wei, X., Xu, Y., Zhang, J., Feng, J., et al. (2024) · Journal of Biological Regulators and Homeostatic Agents/Journal of Biological Regulators & Homeostatic Agents · doi:10.23812/j.biol.regul.homeost.agents.20243801.22

METTL16-Mediated Upregulation of FGD5-AS1 Promotes Progression of Osteosarcoma through Targeting of miR-195-5p/SLC7A2 Axis

Wu, W., Zheng, W., Pan, W., Chen, F., & Jiang, L. (2025) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2025058118

The Hip

Bounajem, G. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-86057-7_13

19/m mit schmerzhafter Schwellung des linken Knies

Hippen, M., KNOLL, A., Bielack, S., Lenz, A., Bokemeyer, C., & Striefler, J. K. (2025) · Die Onkologie · doi:10.1007/s00761-025-01745-w

Isoforsythiaside Impeded Osteosarcoma Progression and Elicited Anti-Tumor Immunity by Suppressing LSD1 Expression

Liu, Y., Shen, X., Wang, Z., & Li, X. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00266-7

LncSNHGs: new targets in osteosarcoma

Zhang, Y., Wu, J., & Liu, J. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00952-2

Deubiquitinase Genes as Prognostic Biomarkers in Osteosarcoma: Insights From Single‐Cell Sequencing and Machine Learning–Based Prognostic Modeling

Zhang, M., Cheng, C., & Liu, G. (2025) · International Journal of Genomics · doi:10.1155/ijog/7932638

A real-world study on the expression and clinical application of IMP3 immunohistochemistry in bone tumors

Wei, Q., Zhong, L., Zhou, H., Jiang, L., Wang, Q., Li, D., & Yang, Q. (2025) · Human Pathology · doi:10.1016/j.humpath.2025.105911

Functional biomaterials meet osteosarcoma treatment

Feng, Y., Huang, H., Zhang, D., Li, Z., Peng, F., Du, H., Liu, X., Chen, L., Pan, H., Wang, N., et al. (2026) · Smart Materials in Medicine · doi:10.1016/j.smaim.2026.04.005

Advances in Nanomaterials for Osteosarcoma Chemotherapy

张, 方. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15113214

Diosgenin Enhances the Sensitivity to Methotrexate Through Oxidative DNA Damage in Saos-2 Osteosarcoma Cancer Cells

Ghobadi, H., Valizadeh, A., Dashti, M., Ghasemzadeh, A., & Yousefi, B. (2025) · Drug Research · doi:10.1055/a-2713-0136

Unveiling Primary Bone Tumors of the Spine: A Review of Essential Imaging Clues

Tregobov, N., Krolikowski, M., Dragoman, R., Brakel, B. A., Munk, P. L., & Heran, M. K. S. (2025) · Diagnostics · doi:10.3390/diagnostics15232970

Construction of an Immunogenic Cell Death-Related Long Non-Coding RNA Signature for Predicting Prognosis in Osteosarcoma

Luo, H. (2025) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2025061145

Pazopanib therapy for children, adolescents, and young adults with relapsed and refractory sarcomas

Tamefusa, K., Ishida, H., Fujiwara, T., Makimoto, G., Ochi, M., Shiwaku, T., Fujiwara, K., Tatebe, Y., Washio, K., Tabata, M., et al. (2025) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaf191

Additional file 1 of LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p

Wang, Z., Wei, Y., Zhu, H., Yu, L., Zhu, J., Han, Q., Liu, Z., Huang, J., Zhu, Y., Fan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226925

Additional file 2 of Long intergenic non-coding RNA DIO3OS promotes osteosarcoma metastasis via activation of the TGF-β signaling pathway: a potential diagnostic and immunotherapeutic target for osteosarcoma

Yuan, J., Jia, J., Wu, T., Du, Z., Chen, Q., Zhang, J., Wu, Z., Yuan, Z. K., Zhao, X., Liu, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24202654

Additional file 4 of P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization

Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22604819

Additional file 2 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

Lu, S., Lu, T., Zhang, J., Gan, L., Wu, X., Han, D., Zhang, K., Xu, C., Liu, S., Qin, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619176

Additional file 1 of Oridonin-induced ferroptosis and apoptosis: a dual approach to suppress the growth of osteosarcoma cells

Zhang, F., Hao, Y., Yang, N., Liu, M., Luo, Y., Zhang, Y., Zhou, J., Liu, H., & Li, J. (2024) · Figshare · doi:10.6084/m9.figshare.26680124

Additional file 2 of Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma

Chen, W., Liao, Y., Sun, P., Tu, J., Zou, Y., Fang, J., Chen, Z., Li, H., Chen, J., Peng, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25010509

Additional file 1 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

Lu, S., Lu, T., Zhang, J., Gan, L., Wu, X., Han, D., Zhang, K., Xu, C., Liu, S., Qin, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619173

Additional file 1 of Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling

Yu, L., Zhu, H., Wang, Z., Jianhao, H., Zhu, Y., Fan, G., Wang, Y., Chen, X., & Zhou, G. (2022) · Figshare · doi:10.6084/m9.figshare.20521595

Additional file 5 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

Lu, S., Lu, T., Zhang, J., Gan, L., Wu, X., Han, D., Zhang, K., Xu, C., Liu, S., Qin, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619185

Additional file 4 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

Lu, S., Lu, T., Zhang, J., Gan, L., Wu, X., Han, D., Zhang, K., Xu, C., Liu, S., Qin, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619182

Additional file 1 of Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity

Wang, H., Jin, X., Zhang, Y., Wang, Z., Zhang, T., Xu, J., Shen, J., Zan, P., Sun, M., Wang, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21303066

Additional file 4 of LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p

Wang, Z., Wei, Y., Zhu, H., Yu, L., Zhu, J., Han, Q., Liu, Z., Huang, J., Zhu, Y., Fan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226937

Additional file 2 of Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)

Xie, L., Liang, X., Xu, J., Sun, X., Liu, K., Sun, K., Li, Y., Tang, X., Li, X., Zhan, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26617597

Additional file 5 of P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization

Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22604822

Additional file 1 of Identification of TNFRSF21 as an inhibitory factor of osteosarcoma based on a necroptosis-related prognostic gene signature and molecular experiments

Li, X., Sun, Z., Ma, J., Yang, M., Cao, H., & 焦广军 (2024) · Figshare · doi:10.6084/m9.figshare.24954483

Additional file 2 of Identification of TNFRSF21 as an inhibitory factor of osteosarcoma based on a necroptosis-related prognostic gene signature and molecular experiments

Li, X., Sun, Z., Ma, J., Yang, M., Cao, H., & 焦广军 (2024) · Figshare · doi:10.6084/m9.figshare.24954555

Additional file 3 of P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization

Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22604816

Additional file 2 of P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization

Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22604813

Additional file 3 of Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma

Chen, W., Liao, Y., Sun, P., Tu, J., Zou, Y., Fang, J., Chen, Z., Li, H., Chen, J., Peng, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26668488

Additional file 3 of LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p

Wang, Z., Wei, Y., Zhu, H., Yu, L., Zhu, J., Han, Q., Liu, Z., Huang, J., Zhu, Y., Fan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226934

Additional file 3 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

Lu, S., Lu, T., Zhang, J., Gan, L., Wu, X., Han, D., Zhang, K., Xu, C., Liu, S., Qin, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619179

Additional file 1 of Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma

Liu, W., Xia, K., Zheng, D., Huang, X., Wei, Z., Wei, Z., & Guo, W. (2023) · Figshare · doi:10.6084/m9.figshare.24715403

Additional file 1 of Engineering a triple-functional magnetic gel driving mutually-synergistic mild hyperthermia-starvation therapy for osteosarcoma treatment and augmented bone regeneration

Yu, K., Zhou, H., Xu, Y., Cao, Y., Zheng, Y., & Liang, B. (2023) · Figshare · doi:10.6084/m9.figshare.23583520

Additional file 1 of Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells

Chen, W., Li, Z., Yu, N., Zhang, L., Li, H., Chen, Y., Gong, F., Lin, W., He, X., Wang, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24223762

Additional file 6 of P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization

Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22604825

Additional file 1 of Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)

Xie, L., Liang, X., Xu, J., Sun, X., Liu, K., Sun, K., Li, Y., Tang, X., Li, X., Zhan, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26617594

Additional file 1 of Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression

Wang, Z., Zeng, Z., Gao, F., Gui, Z., Du, J., Shen, N., Shang, Y., Yang, Z., Shang, L., 魏蓉, et al. (2023) · Figshare · doi:10.6084/m9.figshare.22615100

Additional file 1 of High-performance pyrite nano-catalyst driven photothermal/chemodynamic synergistic therapy for Osteosarcoma

Li, M., Wang, M., Huang, J., Tang, S., Yang, J., Xu, Z., Xu, G., Chen, X., Liu, J., & Yang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26700005

Additional file 3 of Long intergenic non-coding RNA DIO3OS promotes osteosarcoma metastasis via activation of the TGF-β signaling pathway: a potential diagnostic and immunotherapeutic target for osteosarcoma

Yuan, J., Jia, J., Wu, T., Du, Z., Chen, Q., Zhang, J., Wu, Z., Yuan, Z. K., Zhao, X., Liu, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24202660

Additional file 1 of A tumor microenvironment-based prognostic index for osteosarcoma

Wu, C., Gong, S., Duan, Y., Deng, C., Kallendrusch, S., Berninghausen, L. K., Osterhoff, G., & Schopow, N. (2023) · Figshare · doi:10.6084/m9.figshare.22631604

Additional file 4 of Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma

Chen, W., Liao, Y., Sun, P., Tu, J., Zou, Y., Fang, J., Chen, Z., Li, H., Chen, J., Peng, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26668491

Additional file 2 of LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p

Wang, Z., Wei, Y., Zhu, H., Yu, L., Zhu, J., Han, Q., Liu, Z., Huang, J., Zhu, Y., Fan, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226931

Additional file 3 of Identification of TNFRSF21 as an inhibitory factor of osteosarcoma based on a necroptosis-related prognostic gene signature and molecular experiments

Li, X., Sun, Z., Ma, J., Yang, M., Cao, H., & 焦广军 (2024) · Figshare · doi:10.6084/m9.figshare.26664052

Additional file 2 of Oridonin-induced ferroptosis and apoptosis: a dual approach to suppress the growth of osteosarcoma cells

Zhang, F., Hao, Y., Yang, N., Liu, M., Luo, Y., Zhang, Y., Zhou, J., Liu, H., & Li, J. (2024) · Figshare · doi:10.6084/m9.figshare.26680127

Additional file 1 of P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization

Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H., & Yang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22604810

Additional file 2 of Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma

Liu, W., Xia, K., Zheng, D., Huang, X., Wei, Z., Wei, Z., & Guo, W. (2024) · Figshare · doi:10.6084/m9.figshare.24715550

Additional file 6 of CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation

Lu, S., Lu, T., Zhang, J., Gan, L., Wu, X., Han, D., Zhang, K., Xu, C., Liu, S., Qin, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619188

Additional file 1 of Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma

Huang, G., Zhang, X., Xu, Y., Chen, S., Cao, Q., Liu, W. G., Fu, Y., Jia, Q., Shen, J., Yin, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26670855

Reassessing the 8 cm Cutoff: Continuous Tumor Size‐Mortality Risk Supports Three‐Tier Staging in High Grade Osteosarcoma

Dingle, E., Joachim, K., Sparks, O. N., Lin, A. J., Gettleman, B. S., Hamad, C. D., Abernethy, C., Fice, M. P., Bernthal, N. M., & Christ, A. B. (2025) · Journal of Surgical Oncology · doi:10.1002/jso.70181

Establishment and Validation of a Risk Scoring Model Based on Autophagy Subcluster-related Modular Genes for Prognostic Prediction in Osteosarcoma

Lu, X., & Zheng, X. (2026) · Nigerian Postgraduate Medical Journal · doi:10.4103/npmj.npmj_418_25

Molecular guided therapy leading to exceptional response in relapsed osteosarcoma

Wert, E., Menachery, L., Hengst, J. A., Arjmandi, T., Nagulapally, A. B., Gandra, D., Brown, V. I., Sholler, G. S., & Dandekar, S. C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1719832

A tumor microenvironment-triggered biomineralized nanoplatform synergizes with lypressin for tumor blockade therapy

Li, K., Huang, Y., Li, X., Yin, Q., Gong, H., Liu, A., Zhao, G., & Liu, Y. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.115460

Platelet-rich miR-21 is a predictive biomarker in osteosarcoma and promotes osteosarcoma cell malignancy

Pan, X., Dong, S., Sun, F., Zhang, Y., Zhang, G., Li, J., & Liu, B. C. (2026) · General Physiology and Biophysics · doi:10.4149/gpb_20250371

Genistein-loaded mesenchymal stem cells (MSCs)-derived exosomes: A novel drug carrier for targeted osteosarcoma treatment via PPARγ pathway

Gu, Z., Zhang, S., Li, G., Hu, X., Xu, N., Wang, Y. A., Ruan, J., Ma, W., & Chen, H. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107862

Differential expression of CD74 and C1QB in jaw versus long bone osteosarcoma: Insights from animal models, public datasets and clinical cohorts

Zhang, L., Liu, J., Shao, S., Liu, X., Zhang, L., & Wang, W. (2026) · Journal of bone oncology · doi:10.1016/j.jbo.2026.100742

Prognostic Value of microRNA ‐648 in Osteosarcoma and Its Regulatory Effect on Tumor Progression

Deng, B., Wang, P., Wang, M., Li, L., & Huang, N. (2026) · Apmis · doi:10.1111/apm.70144

Glutathione-responsive deformable manganese-based nanomedicines for enhanced tumor-specific chemotherapy

Li, P., Tao, J., Yi, X., Qi, Q., Liang, Z., Wu, Y., Xirena, W., Ye, C., Ke, Y., Wang, L., et al. (2026) · RSC Advances · doi:10.1039/d6ra00177g

Endoscopic Debulking in the Management of Osteosarcoma With a Rare Endobronchial Metastasis

Jang, J., Bouzarif, G., & Hsia, D. W. (2026) · Cureus · doi:10.7759/cureus.103501

Tongguanteng Injection Inhibits Osteosarcoma Progression via the ER Stress-Linked IRE1/CHOP Pathway

Grabowski, M. T., & Lis, A. P. (2023) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/p1poyjkan3

Allicin inhibits PD-L1 through the IL-6/JAK2/STAT3 pathway to suppress immune evasion in osteosarcoma

Gong, R., Xi-min, J., Cui, X., Sun, J.-H., Xie, W., & Zhang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1735090

Exploring the drivers of price variation in orthopaedic radical bone tumor resection: A nationwide database study

Shenoy, D. A., Cruz, W. C., Bhat, S., Parsons, K. E., Therien, A. D., Wu, K. A., Pean, C. A., & Eward, W. C. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343676

Noncoding RNAs in Pediatric Solid Tumors: Advances in Understanding and Critical Knowledge Gaps

Duff, G., Mella, C., Amato-Loudon, A., Farrell, M., Aldridge, R., & Ball, H. C. (2026) · Cells · doi:10.3390/cells15050465

Prognostic and Immunomodulatory Roles of BNIP3 in Osteosarcoma Revealed by Integrated Single‐Cell and Bulk Transcriptomic Profiling

Li, J., Wang, W., Li, L., & Yu, K. (2026) · International Journal of Genomics · doi:10.1155/ijog/9272264

The ITGB2‐COPS3‐SOX2 Axis and SOX2 Liquid‐Liquid Phase Separation: Dual Mechanisms Governing Osteosarcoma Stemness

Guo, L., Zhao, Z., Wang, W., Niu, J., Wang, B., Lin, Y., Guo, W., & Yan, T. (2026) · Advanced Science · doi:10.1002/advs.202520913

Harnessing the immune system against osteosarcoma: from tumor microenvironment modulation to combinatorial immunotherapies

Duan, L. L., Zhu, H., Chen, C., & Liu, W. (2026) · Holistic Integrative Oncology · doi:10.1007/s44178-026-00226-3

Glutathione metabolic reprogramming by ferroptosis inducers potentiates cuproptosis and antitumor immunity in osteosarcoma

Xu, S., Zhao, Y., Yao, J., Chen, H., Lyu, J., Ding, Y., Zeng, H., Chen, H., Hu, C., & Zhao, C. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116495

A study of suicide risk and prognostic characteristics in patients with osteosarcoma

Du, J., Gao, J., Yao, Y., & Shen, Z. (2026) · Clinical and investigative medicine · doi:10.3138/cim-2025-0139

Effects of social support on caregiver benefit in pediatric osteosarcoma: A single-center cross-sectional study

Chen, J., Fu, L., Wang, R., Zhao, X., & Sui, L. (2026) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2026.03.021

RNF130 inhibits the proliferation, migration and invasion of osteosarcoma through DAB1 mediated suppression of the PI3K/AKT signaling pathway

Liu, W., Guo, L., Liu, Z., & Guo, W. J. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112506

Chemo-Nonresponsive Telangiectatic Osteosarcoma With Oligometastatic Recurrence Managed With Multimodality Therapy Including Stereotactic Ablative Body Radiotherapy (SABR): A Case Report With a Pathologic Treatment Effect

Orr, W. S., Vijayakumar, S., Hmada, Y. A., Mobit, P., Collier, A. B., Barr, J., de Delva, P. E., Davis, D. B., Yang, C. C., & Nittala, M. R. (2026) · Cureus · doi:10.7759/cureus.106242

E3 Ubiquitin Ligase ITCH Enhances P53 Ubiquitination-Dependent Degradation and Drives Osteosarcoma Tumorigenesis

Zeng, J., Zhan, H., Xiao, J., Huang, F., & Bian, W. (2026) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-25-0687

The prognostic value and oncogenic functions of WDR12 and its validation in osteosarcoma

Zhang, Z., Chen, R., Liu, Z., Liu, B., Mei, L., Yin, C., Wan, L., & Li, Z. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04291-6

Habitat-based MRI heterogeneity radiomics for predicting neoadjuvant chemotherapy response in osteosarcoma

Wang, S., Wang, Q., Wan, X., Meng, X., Sun, M., Sun, J., Yu, X., Wang, G., Zhu, L., & Yu, H. (2026) · European Journal of Radiology · doi:10.1016/j.ejrad.2026.112853

Development and validation of a biopsy-based model using tumor-associated neutrophils to predict neoadjuvant chemotherapy response in osteosarcoma: a large single-center retrospective cohort study

Feng, W., Xu, Z., Yan, Z., Wu, H., Guo, H., Luo, Y., & Liu, W. T. (2026) · Journal of bone oncology · doi:10.1016/j.jbo.2026.100764

Osteosarcoma – conventional treatment vs. gene therapy

Tan, M. L., Choong, P., & Dass, C. R. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.2.7385 · Cited by 99

From biology to personalized medicine: Recent knowledge in osteosarcoma

Mohr, A., Costa, M. E. M. D., Fromigué, O., Audinot, B., Balde, T., Droit, R., Abbou, S. D., Khneisser, P., Berlanga, P., Pérez, E., et al. (2024) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2024.104941 · Cited by 13

The Genetics of Osteosarcoma

Martin, J. W., Squire, J. A., & Zieleńska, M. (2012) · Sarcoma · doi:10.1155/2012/627254 · Cited by 254

Making gene therapy for osteosarcoma a reality

Broadhead, M. L., Clark, J. C. M., Choong, P., & Dass, C. R. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.18 · Cited by 12

Genome-Informed Targeted Therapy for Osteosarcoma

Sayles, L. C., Breese, M. R., Koehne, A. L., Leung, S. G., Lee, A. G., Liu, H.-Y., Spillinger, A., Shah, A. T., Tanasa, B., Straessler, K., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1152 · Cited by 452